A short-term n-3 DPA supplementation study in humans

Area of Science:

• Biochemistry
• Human Nutrition
• Omega-3 Fatty Acids

Background:

• Limited understanding of docosapentaenoic acid (DPA) metabolism compared to EPA and DHA.
• Plasma lipids and red blood cells (RBC) are key sites for fatty acid incorporation.

Purpose of the Study:

• To investigate the uptake and incorporation of pure DPA and EPA into human plasma and RBC lipids.
• To compare the distinct incorporation patterns of DPA and EPA.

Main Methods:

• Ten female participants received 8g of pure DPA or EPA in a randomized crossover, double-blinded manner over 7 days.
• Placebo treatment involved olive oil.
• Blood samples were collected on days 0, 4, and 7 for plasma and RBC fatty acid analysis.

Main Results:

• DPA supplementation increased DPA in plasma phospholipids and triacylglycerols, and also increased EPA and DHA in plasma lipids.
• EPA supplementation increased EPA in plasma cholesterol esters and phospholipids, and in RBC phospholipids.
• Neither DPA nor EPA supplementation altered the proportions of the other fatty acids in RBC phospholipids, indicating specific incorporation patterns.

Conclusions:

• Short-term DPA supplementation leads to distinct incorporation patterns in human plasma lipids.
• DPA may function as a reservoir for major long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFA) in humans.